These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26805349)

  • 1. [A Case of Locally Advanced Rectal Cancer with a Pathological Complete Response to Preoperative Chemoradiotherapy].
    Akahoshi S; Iizaka M; Murakami S; Nimura S; Takeguchi T
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2316-8. PubMed ID: 26805349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of locally advanced rectal carcinoma treated with preoperative chemoradiotherapy resulting in pathologically complete response].
    Katsuyama S; Murata M; Tanaka N; Asai K; Saso K; Yagi T; Yamada M; Sawami H; Takahashi H; Takayama O; Baba M; Kondo S; Son M; Kimura H; Fukuda H; Yamamoto M; Hiratsuka M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1563-5. PubMed ID: 25731253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
    Vestermark LW; Jensen HA; Pfeiffer P
    Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis.
    Nakagawa R; Inoue Y; Ohki T; Kaneko Y; Maeda F; Yamamoto M
    World J Surg Oncol; 2017 May; 15(1):112. PubMed ID: 28566093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case report of pathologically complete response of rectal cancer after preoperative treatment of CPT-11, S-1, and radiation therapy].
    Hamanaka M; Yamano T; Noda M; Tsukamoto K; Kuno T; Yamagishi D; Babaya A; Matsubara N; Kamikonya N; Tomita N
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2253-5. PubMed ID: 22202346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression levels of gamma-glutamyl hydrolase in tumor tissues may be a useful biomarker for the proper use of S-1 and tegafur-uracil/leucovorin in preoperative chemoradiotherapy for patients with rectal cancer.
    Sadahiro S; Suzuki T; Tanaka A; Okada K; Saito G; Miyakita H; Ogimi T; Nagase H
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1077-1085. PubMed ID: 28417167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of long-term survival after resection of advanced undifferentiated rectal cancer treated by short-term preoperative chemoradiotherapy and postoperative adjuvant chemotherapy].
    Naito Y; Hashiguchi Y; Ueno H; Kajiwara Y; Shimazaki H; Mochizuki H; Hase K
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):117-20. PubMed ID: 21368471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of locally advanced rectal cancer successfully treated by laparoscopic intersphincteric resection and effective neoadjuvant chemoradiation therapy].
    Kanamoto A; Nakano T; Ojima E; Sasaki S
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1974-7. PubMed ID: 24393984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of pathological response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Tomono A; Yamashita K; Kanemitsu K; Sumi Y; Yamamoto M; Kanaji S; Imanishi T; Nakamura T; Suzuki S; Tanaka K; Kakeji Y
    Int J Clin Oncol; 2016 Apr; 21(2):344-349. PubMed ID: 26338272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: a phase II TCOG study.
    Wang LW; Hsiao CF; Chen WT; Lee HH; Lin TC; Chen HC; Chen HH; Chien CR; Lin TY; Liu TW
    J Surg Oncol; 2014 May; 109(6):580-5. PubMed ID: 24374744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I/II Study of Preoperative Chemoradiotherapy With TEGAFIRI for Locally Advanced Rectal Cancer.
    Kawai K; Sunami E; Hata K; Tanaka T; Nishikawa T; Otani K; Sasaki K; Nozawa H
    Clin Colorectal Cancer; 2018 Sep; 17(3):240-246. PubMed ID: 29934092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complete disappearance of pulmonary metastases in a case of rectal cancer treated with oral tegafur-uracil (UFT) and leucovorin (LV)].
    Takada A; Kawahara M; Kobayashi H; Takino Y; Kodama T; Sugishita T; Ohno Y; Oka T; Tsukamoto F
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):997-9. PubMed ID: 22705701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of tegafur-uracil and leucovorin in chemoradiotherapy for rectal cancer.
    Ishihara S; Hayama T; Yamada H; Nozawa K; Matsuda K; Watanabe T
    Hepatogastroenterology; 2011; 58(107-108):756-62. PubMed ID: 21830385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of preoperative chemoradiotherapy on advanced low rectal cancer.
    Kao PS; Chang SC; Wang LW; Lee RC; Liang WY; Lin TC; Chen WS; Jiang JK; Yang SH; Wang HS; Lin JK
    J Surg Oncol; 2010 Dec; 102(7):771-7. PubMed ID: 20872811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.
    Atasoy BM; Abacioglu U; Dane F; Ozgen Z; Yumuk PF; Ozden S; Akgun Z; Mayadagli A; Basaran G; Turhal S; Sengoz M
    J BUON; 2007; 12(2):203-8. PubMed ID: 17600873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Number of Lymph Nodes in Rectal Cancer is Correlated with Response to Preoperative Chemoradiotherapy but is not Associated with Patient Survival.
    Ishihara S; Fukushima Y; Akahane T; Horiuchi A; Shimada R; Nakamura K; Aoyagi Y; Hayama T; Yamada H; Nozawa K; Matsuda K; Hashiguchi Y; Watanabe T
    Hepatogastroenterology; 2014 Jun; 61(132):1000-7. PubMed ID: 26158156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative chemoradiotherapy with oxaliplatin and tegafur-uracil in locally advanced rectal cancer: pathologic complete response rate and preliminary results of overall and disease-free survival in a single institute in Taiwan.
    Chao JY; Wang HM; Chiang FF; Lin JC; Chang CF; Lin JF; Yeh HL
    J Chin Med Assoc; 2014 Mar; 77(3):128-32. PubMed ID: 24398439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of advanced rectal cancer that showed complete response to the addition of XELOX+bevacizumab therapy to preoperative chemoradiotherapy with S-1/CPT-11].
    Takahashi T; Namiki K; Matsumoto H; Konno F; Mitsui K; Yoshida R
    Gan To Kagaku Ryoho; 2014 May; 41(5):653-5. PubMed ID: 24917016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I study of oral UFT given concomitantly with standard preoperative radiotherapy for rectal cancer.
    Pfeffer MR; Kundel Y; Zehavi M; Catane R; Koller M; Zmora O; Elkayam R; Symon Z
    Isr Med Assoc J; 2004 Oct; 6(10):595-8. PubMed ID: 15473585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.